All Releases
 |
AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results
Sep 7, 2010
|
10.7 KB |
|
| |
ALBANY, N.Y., Sep 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, today reported preliminary unaudited
results for its fiscal 2011 first quarter ended August 31, 2010.
AngioDynamics expec...
|
|
AngioDynamics Expands Its VenaCure EVLT ™ System to Offer Physicians Fewer Procedure Steps and a Faster Procedure Time
Aug 30, 2010
|
11.2 KB |
|
| |
ALBANY, N.Y., Aug 30, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO) announced today the launch of a new
access kit allowing fewer procedure steps and faster procedure time for
physicians using the VenaCure EVLT system's NeverTouch(R)
gold-tip laser fiber to treat varicose veins.
The new .018-inch system for the VenaC...
|
|
AngioDynamics to Participate in the 30th Annual Canaccord Genuity Growth Conference
Aug 3, 2010
|
8.2 KB |
|
| |
ALBANY, N.Y., Aug 03, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 30th
Annual Canaccord Genuity Growth Conference in Boston on Thursday, August ...
|
|
AngioDynamics Reports Strong Finish to Fiscal 2010
Jul 15, 2010
|
30.3 KB |
|
| |
ALBANY, N.Y., Jul 15, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, today reported financial results for the
fiscal fourth quarter and year ended May 31, 2010.
Net sales in the fourth quar...
|
|
AngioDynamics Expands Power-Injectable Port Portfolio with the Smart Port® CT Low-Profile and Mini Models
Jul 12, 2010
|
11.4 KB |
|
| |
ALBANY, N.Y., Jul 12, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) announced today the global expansion
of its Smart Port CT family of power-injectable ports, featuring its
patented Vortex(R) port technology - to include low-profile and
mini models for repeated treatments such as chemotherapy and for use
with ...
|
|
AngioDynamics to Hold Fiscal 2010 Fourth Quarter and Full Year Financial Results Conference Call on July 15, 2010
Jun 17, 2010
|
8.9 KB |
|
| |
ALBANY, N.Y., Jun 17, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will report its fiscal 2010
fourth quarter and full year financial results on Thursday, July 15,
...
|
|
AngioDynamics Appoints Lynda Wallace Senior Vice President of Business Development
May 20, 2010
|
11.2 KB |
|
| |
ALBANY, N.Y., May 20, 2010 (BUSINESS WIRE) -- AngioDynamics
(NASDAQ: ANGO) today announced the appointment of Lynda Wallace, 47, as
Senior Vice President of Business Development. In this capacity, Ms.
Wallace will lead AngioDynamics' business development and strategic
planning activities and join the Company's execut...
|
|
AngioDynamics Launches First Product in Morpheus® Smart PICC Series, a Triple Lumen Version for CT Imaging
May 17, 2010
|
11.1 KB |
|
| |
ALBANY, N.Y., May 17, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) announced today the launch of the first
member of its new generation of peripherally inserted central catheters
(PICCs) for procedures involving the use of contrast media in computed
tomography (CT) - the Morpheus Smart PICC Triple Lumen CT PICC.
"Thi...
|
|
AngioDynamics Launches Improved Centros® Self-Centering Hemodialysis Catheter
May 10, 2010
|
12.4 KB |
|
| |
ALBANY, N.Y., May 10, 2010 (BUSINESS WIRE) -- AngioDynamics
(NASDAQ:ANGO) announced today it has achieved the national launch of the
newly redesigned Centros self-centering, chronic hemodialysis access
catheter.
The Centros hemodialysis access catheter employs Curved Tip(TM) Catheter
Technology that is designed to p...
|
|
AngioDynamics to Participate in the Bank of America Merrill Lynch Health Care Conference
May 4, 2010
|
8.7 KB |
|
| |
ALBANY, N.Y., May 04, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the Bank of
America Merrill Lynch Health Care Conference in New York City on
...
|
|
AngioDynamics' VenaCure EVLT™System for Varicose Veins To Be Featured On 'The Doctors' National Television Program
Apr 29, 2010
|
10.6 KB |
|
| |
ALBANY, N.Y. April 29, 2010 - AngioDynamics (NASDAQ: ANGO) announced today that on Friday, April 30, the company's VenaCure EVLT varicose vein laser treatment system is expected to be featured in a segment on the popular television show "The Doctors."
"The Doctors" is a one-hour, syndicated daytime television program that provides...
|
|
AngioDynamics to Participate in the Deutsche Bank 35th Annual Health Care Conference
Apr 27, 2010
|
8.7 KB |
|
| |
ALBANY, N.Y., Apr 27, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the Deutsche
Bank 35th Annual Health Care Conference in Boston on Monday,
...
|
|
AngioDynamics Announces First Patient Treatment and Ongoing Enrollment in the Clinical Trial of the Use of IRE Technology in the Treatment of Early Stage Primary Liver Cancer
Apr 20, 2010
|
11.6 KB |
|
| |
QUEENSBURY, N.Y., Apr 20, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) today announced the first patient treatment
and growing enrollment in a pilot study of the use of the Company's
NanoKnife(R) Irreversible Electroporation (IRE) System in the
treatment of early stage hepatocellular carcinoma (HCC), or primary
...
|
|
AngioDynamics Reports Fiscal Third Quarter 2010 Results
Mar 31, 2010
|
30.5 KB |
|
| |
ALBANY, N.Y., Mar 31, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, today reported financial results for the
fiscal third quarter ended February 28, 2010.
Net sales in the third quarter tot...
|
|
AngioDynamics Opens Corporate Headquarters
Mar 29, 2010
|
11.3 KB |
|
| |
LATHAM, N.Y. March 29, 2010 - AngioDynamics (NASDAQ: ANGO) announced today the opening of its new corporate headquarters, based in the Albany region of New York State.
Seventy AngioDynamics employees are now based at the new three-story building, including President and CEO Jan Keltjens. Other departments at the new site include t...
|
|
AngioDynamics Welcomes Recently Published Book on Irreversible Electroporation and Patient Experiences
Mar 22, 2010
|
9.4 KB |
|
| |
QUEENSBURY, N.Y., Mar 22, 2010 (BUSINESS WIRE) -- AngioDynamics
(NASDAQ:ANGO) today welcomed the publication of the book "Irreversible
Electroporation," published by Springer Berlin Heidelberg.
The book is edited by Boris Rubinsky, a Professor of the Graduate School
at the University of California, Berkeley.
The book's cha...
|
|
AngioDynamics to Hold Fiscal 2010 Third Quarter Financial Results Conference Call on March 31, 2010
Mar 15, 2010
|
9.0 KB |
|
| |
QUEENSBURY, N.Y., Mar 15, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, announced today that it has changed the
date that it will report its fiscal 2010 third quarter financial results
...
|
|
AngioDynamics to Hold Fiscal 2010 Third Quarter Financial Results Conference Call on April 1, 2010
Mar 11, 2010
|
9.0 KB |
|
| |
QUEENSBURY, N.Y., Mar 11, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, announced today that it will report its
fiscal 2010 third quarter financial results on Thursday, April 1, 2010,
...
|
|
AngioDynamics' VenaCure EVLT™ Varicose Vein Treatment Featured By FOX News
Jan 25, 2010
|
13.0 KB |
|
| |
QUEENSBURY, N.Y. January 25, 2010 - AngioDynamics (NASDAQ: ANGO) today highlighted coverage of its VenaCure EVLT treatment for varicose veins on FOX affiliates across the United States. The television segment can be accessed online at the web address bit.ly/venacure-evlt.
In the feature, F...
|
|
AngioDynamics to Participate in the 28th Annual J.P. Morgan Healthcare Conference
Jan 7, 2010
|
8.5 KB |
|
| |
QUEENSBURY, N.Y., Jan 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 28th
Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday...
|
|
|
